Dermata Therapeutics, Inc. Profile Avatar - Palmy Investing

Dermata Therapeutics, Inc.

Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions. The company's lead product candidate…

Biotechnology
US, San Diego [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Dermata Therapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Dermata Therapeutics, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Dermata Therapeutics, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of DRMA's Analysis
CIK: 1853816 CUSIP: 249845108 ISIN: US2498453065 LEI: - UEI: -
Secondary Listings
DRMA has no secondary listings inside our databases.